OncoMatch/Clinical Trials/NCT06918054

Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

Is NCT06918054 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies non-drug interventions for leukaemia (acute).

Phase 4RecruitingAin Shams UniversityNCT06918054Data as of May 2026

This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.

Check if I qualify

Extracted eligibility criteria

Cancer type

Acute Lymphoblastic Leukemia

Prior therapy

No prior treatment (treatment-naive required)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify